Biocatalysis: A Status Report

Annual Review of Chemical and Biomolecular Engineering

Volumn 6, Issue , 2015, Pages 319-345

  Bommarius, Andreas S ^a  

^a Georgia Institute of Technology   (United States)

Author keywords

biocatalyst; enzyme; protein engineering; stabilization

Indexed keywords

BIOCATALYSTS; BIOCHEMICAL ENGINEERING; CATALYSIS; GENETIC ENGINEERING; PROTEINS; STABILIZATION;

BIOCATALYSIS; BIOCATALYST DEVELOPMENT; DESIGNABILITY; NOVEL PROTEINS; PROTEIN ENGINEERING; RATIONAL MODELS; READY TO USE; SYNTHETIC CHEMISTRY;

ENZYMES;

PROTEIN;

ANIMAL; BIOCATALYSIS; CHEMISTRY; ENZYME STABILITY; GENETICS; HUMAN; METABOLISM; PROCEDURES; PROTEIN ENGINEERING;

ANIMALS; BIOCATALYSIS; ENZYME STABILITY; HUMANS; PROTEIN ENGINEERING; PROTEINS;

EID: 84938796452     PISSN: 19475438     EISSN: None     Source Type: Journal    
DOI: 10.1146/annurev-chembioeng-061114-123415     Document Type: Article

References (110)

1. Turner NJ. 2009. Directed evolution drives the next generation of biocatalysts. Nat. Chem. Biol. 5:568-74
2. Bornscheuer UT, Huisman GW, Kazlauskas RJ, Lutz S, Moore JC, Robins K. 2012. Engineering the third wave of biocatalysis. Nature 485:185-94
3. Reetz MT. 2013. Biocatalysis in organic chemistry and biotechnology: past, present, and future. J. Am. Chem. Soc. 135:12480-96
4. Chambers I, Frampton J, Goldfarb P, Affara N, McBain W, Harrison PR. 1986. The structure of the mouse glutathione-peroxidase gene: the selenocysteine in the active-site is encoded by the 'termination' codon, TGA. EMBO J. 5:1221-27
5. Zinoni F, Birkmann A, Stadtman TC, Bock A. 1986. Nucleotide-sequence and expression of the selenocysteine-containing polypeptide of formate dehydrogenase (formate-hydrogen-lyase-linked) from Escherichia coli. Proc. Natl. Acad. Sci. USA 83:4650-54
6. Srinivasan G, James CM, Krzycki JA. 2002. Pyrrolysine encoded by UAG in Archaea: charging of a UAG-decoding specialized tRNA. Science 296:1459-62
7. Hao B,GongWM, Ferguson TK, James CM,Krzycki JA, Chan MK. 2002. A new UAG-encoded residue in the structure of a methanogen methyltransferase. Science 296:1462-66
8. Ngo JT, Tirrell DA. 2011. Noncanonical amino acids in the interrogation of cellular protein synthesis. Acc. Chem. Res. 44:677-85
9. Xiao H, Chatterjee A, Choi SH, Bajjuri KM, Sinha SC, Schultz PG. 2013. Genetic incorporation of multiple unnatural amino acids into proteins in mammalian cells. Angew. Chem. Int. Ed. 52:14080-83
10. Rosenzweig R, Kay LE. 2014. Bringing dynamic molecular machines into focus by methyl-TROSY NMR. Annu. Rev. Biochem. 83:291-15
11. Oikawa H, Kobayashi T, Katayama K, Suzuki Y, Ichihara A. 1998. Total synthesis of solanapyrone A via enzymatic Diels-Alder reaction of prosolanapyrone. J. Organ. Chem. 63:8748-56
12. Reetz MT, Mondiere R, Carballeira JD. 2007. Enzyme promiscuity: first protein-catalyzed Morita-Baylis-Hillman reaction. Tetrahedron Lett. 48:1679-81
13. Rothlisberger D, Khersonsky O, Wollacott AM, Jiang L, DeChancie J, et al. 2008. Kemp elimination catalysts by computational enzyme design. Nature 453:190-95
14. AbrahamsonMJ, Vazquez-Figueroa E,Woodall NB,Moore JC, Bommarius AS. 2012. Development of an amine dehydrogenase for synthesis of chiral amines. Angew. Chem. Int. Ed. 51:3969-72
15. Coelho PS, Brustad EM, Kannan A, Arnold FH. 2013. Olefin cyclopropanation via carbene transfer catalyzed by engineered cytochrome P450 enzymes. Science 339:307-10
16. Fersht A. 1999. Structure and Mechanism in Protein Science. New York: Freeman
17. Radzicka A,Wolfenden R. 1995. A proficient enzyme. Science 267:90-93
18. Taylor EA, Palmer DRJ, Gerlt JA. 2001. The lesser burden borne by o-succinylbenzoate synthase: an easy reaction involving a carboxylate carbon acid. J. Am. Chem. Soc. 123:5824-25
19. Wolfenden R, Snider MJ. 2001. The depth of chemical time and the power of enzymes as catalysts. Acc. Chem. Res. 34:938-45
20. Notomista E, Cafaro V, Bozza G, Di Donato A. 2009. Molecular determinants of the regioselectivity of toluene/o-xylene monooxygenase from Pseudomonas sp. strain OX1. Appl. Environ. Microbiol. 75:823-36
21. He ZQ,Nadeau LJ, Spain JC. 2000. Characterization of hydroxylaminobenzenemutase from pNBZ139 cloned from Pseudomonas pseudoalcaligenes JS45. Eur. J. Biochem. 267:1110-16
22. Hu S, Huang J, Mei LH, Yu Q, Yao SJ, Jin ZH. 2010. Altering the regioselectivity of cytochrome P450 BM-3 by saturation mutagenesis for the biosynthesis of indirubin. J. Mol. Catal. B: Enzymatic 67:29-35
23. Chenault HK, Dahmer J, Whitesides GM. 1989. Kinetic resolution of unnatural and rarely occurring amino acids: enantioselective hydrolysis of N-acyl amino acids catalyzed by acylase I. J. Am. Chem. Soc. 111:6354-64
24. Wu Q, Soni P, Reetz MT. 2013. Laboratory evolution of enantiocomplementary Candida antarctica lipase B mutants with broad substrate scope. J. Am. Chem. Soc. 135:1872-81
25. ReetzMT, Wang LW, BocolaM. 2006. Directed evolution of enantioselective enzymes: iterative cycles of CASTing for probing protein-sequence space. Angew. Chem. Int. Ed. 45:1236-41
26. Bommarius AS,Drauz K,HummelW,KulaMR, WandreyC. 1994. Some new developments in reductive amination with cofactor regeneration. Biocatalysis 10:37-47
27. AbrahamsonMJ, Wong JW, Bommarius AS. 2013. The evolution of an amine dehydrogenase biocatalyst for the asymmetric production of chiral amines. Adv. Synth. Catal. 355:1780-86
28. Reetz MT, Kahakeaw D, Lohmer R. 2008. Addressing the numbers problem in directed evolution. ChemBioChem 9:1797-804
29. ReetzMT, Bocola M, Carballeira JD, Zha DX, Vogel A. 2005. Expanding the range of substrate acceptance of enzymes: combinatorial active-site saturation test. Angew. Chem. Int. Ed. 44:4192-96
30. Reetz MT. 2011. Laboratory evolution of stereoselective enzymes: a prolific source of catalysts for asymmetric reactions. Angew. Chem. Int. Ed. 50:138-74
31. Reetz MT, Carballeira JD. 2007. Iterative saturation mutagenesis (ISM) for rapid directed evolution of functional enzymes. Nat. Protoc. 2:891-903
32. Bommarius AS, Schwarm M, Drauz K. 2001. Comparison of different chemoenzymatic process routes to enantiomerically pure amino acids. Chimia 55:50-59
33. Rozzell JD. 1999. Biocatalysis at commercial scale:myths and realities. Chim. Oggi-Chem. Today 17:42-47
34. Wandrey A, Seelbach K, Wandrey C. 2006. Industrial Biotransformations. Weinheim, Ger. : Wiley-VCH. 570 pp.
35. Lumry R, Eyring H. 1954. Conformation changes of proteins. J. Phys. Chem. 58:110-20
36. Rogers TA, Bommarius AS. 2010. Utilizing simple biochemical measurements to predict lifetime output of biocatalysts in continuous isothermal processes. Chem. Eng. Sci. 65:2118-24
37. Eisenthal R, Danson MJ, Hough DW. 2007. Catalytic efficiency and kcat/KM: a useful comparator? Trends Biotechnol. 25:247-49
38. Ceccarelli EA, Carrillo N, Roveri OA. 2008. Efficiency function for comparing catalytic competence. Trends Biotechnol. 26:117-18
39. Fox RJ, Clay MD. 2009. Catalytic effectiveness, a measure of enzyme proficiency for industrial applications. Trends Biotechnol. 27:137-40
40. Palackal N, Brennan Y, Callen WN, Dupree P, Frey G, et al. 2004. An evolutionary route to xylanase process fitness. Protein Sci. 13:494-503
41. Voigt CA, Martinez C, Wang Z-G, Mayo SL, Arnold FH. 2002. Protein building blocks preserved by recombination, Nature Struct. Biol. 9:553-58
42. Meyer MM, Silberg JJ, Voigt CA, Endelman JB, Mayo SL, et al. 2003. Library analysis of SCHEMAguided protein recombination, Protein Sci. 12:1686-93
43. Heinzelman P, Snow CD, Wu I, Nguyen C, Villalobos A, et al. 2009. A family of thermostable fungal cellulases created by structure-guided recombination. Proc. Natl. Acad. Sci. USA 106:5610-15
44. Heinzelman P, SnowCD, SmithMA, Yu XL,Kannan A, et al. 2009. SCHEMArecombination of a fungal cellulase uncovers a single mutation that contributes markedly to stability. J. Biol. Chem. 284:26229-33
45. Heinzelman P, Komor R, Kanaan A, Romero P, Yu XL, et al. 2010. Efficient screening of fungal cellobiohydrolase class I enzymes for thermostabilizing sequence blocks by SCHEMA structure-guided recombination. Protein Eng. Des. Select. 23:871-80
46. Anbar M, Bayer EA. 2012. Approaches for improving thermostability characteristics in cellulases. Cellulases 510:261-71
47. Steipe B, Schiller B, Pluckthun A, Steinbacher S. 1994. Sequence statistics reliably predict stabilizing mutations in a protein domain. J. Mol. Biol. 240:188-92
48. Lehmann M, Pasamontes L, Lassen SF, Wyss M. 2000. The consensus concept for thermostability engineering of proteins. Biochim. Biophys. Acta-Protein Struct. Mol. Enzymol. 1543:408-15
49. Lehmann M, Loch C, Middendorf A, Studer D, Lassen SF, et al. 2002. The consensus concept for thermostability engineering of proteins: further proof of concept. Protein Eng. 15:403-11
50. Amin N, Liu AD, Ramer S, Aehle W, Meijer D, et al. 2004. Construction of stabilized proteins by combinatorial consensus mutagenesis. Protein Eng. Des. Sel. 17:787-93
51. Vazquez-Figueroa E, Yeh V, Broering JM, Chaparro-Riggers JF, Bommarius AS. 2008. Thermostable variants constructed via the structure-guided consensus method also show increased stability in salts solutions and homogeneous aqueous-organic media. Protein Eng. Des. Sel. 21:673-80
52. Baik SH, Ide T, Yoshida H, Kagami O, Harayama S. 2003. Significantly enhanced stability of glucose dehydrogenase by directed evolution. Appl. Microbiol. Biotechnol. 61:329-35
53. Reetz MT, Soni P, Acevedo JP, Sanchis J. 2009. Creation of an amino acid network of structurally coupled residues in the directed evolution of a thermostable enzyme. Angew. Chem. Int. Ed. 48:8268-72
54. Blum JK, Ricketts MD, Bommarius AS. 2012. Improved thermostability of AEH by combining B-FIT analysis and structure-guided consensus method. J. Biotechnol. 160:214-21
55. Wijma HJ, Floor RJ, Jekel PA, Baker D, Marrink SJ, Janssen DB. 2014. Computationally designed libraries for rapid enzyme stabilization. Protein Eng. Des. Sel. 27:49-58
56. Bommarius AS, Paye MF. 2013. Stabilizing biocatalysts. Chem. Soc. Rev. 42:6534-65
57. Cowan DA. 1997. Thermophilic proteins: stability and function in aqueous and organic solvents. Comp. Biochem. Physiol.-Mol. Integr. Physiol. 118:429-38
58. Owusu RK, Cowan DA. 1989. Correlation between microbial protein thermostability and resistance to denaturation in aqueous-organic solvent 2-phase systems. Enzyme Microb. Technol. 11:568-74
59. Hao JJ, Berry A. 2004. A thermostable variant of fructose bisphosphate aldolase constructed by directed evolution also shows increased stability in organic solvents. Protein Eng. Des. Sel. 17:689-97
60. ReetzMT, Soni P, Fernandez L,Gumulya Y, Carballeira JD. 2010. Increasing the stability of an enzyme toward hostile organic solvents by directed evolution based on iterative saturation mutagenesis using the B-FIT method. Chem. Commun. 46:8657-58
61. Adalbjörnsson BV, Toogood HS, Fryszkowska A, Pudney CR, Jowitt TA, et al. 2010. Biocatalysis with thermostable enzymes: structure and properties of a thermophilic 'ene'-reductase related to old yellow enzyme. ChemBioChem 11:197-207
62. Sharma S, Mittal A, Gupta VK, Singh H. 2007. Improved stabilization of microencapsulated Cathepsin B in harsh conditions. Enzyme Microb. Technol. 40:337-42
63. Slusarczyk H, Felber S, Kula MR, Pohl M. 2000. Stabilization of NAD-dependent formate dehydrogenase from Candida boidinii by site-directedmutagenesis of cysteine residues. Eur. J. Biochem. 267:1280-89
64. Bommarius AS, Karau A. 2005. Deactivation of formate dehydrogenase (FDH) in solution and at gasliquid interfaces. Biotechnol. Prog. 21:1663-72
65. Gadler P, Reiter TC, Hoelsch K, Weuster-Botz D, Faber K. 2009. Enantiocomplementary inverting sec-alkylsulfatase activity in cyano-and thio-bacteria Synechococcus and Paracoccus spp. : selectivity enhancement by medium engineering. Tetrahedron-Asymmetry 20:115-18
66. Schober M, Gadler P, Knaus T, Kayer H, Birner-Grunberger R, et al. 2011. A stereoselective inverting sec-alkylsulfatase for the deracemization of sec-alcohols. Org. Lett. 13:4296-99
67. Schober M, Knaus T, Toesch M, Macheroux P, Wagner U, Faber K. 2012. The substrate spectrum of the inverting sec-alkylsulfatase Pisa1. Adv. Synth. Catal. 354:1737-42
68. SchoberM, ToeschM, Knaus T, Strohmeier GA, van Loo B, et al. 2013. One-pot deracemization of secalcohols: enantioconvergent enzymatic hydrolysis of alkyl sulfates using stereocomplementary sulfatases. Angew. Chem. Int. Ed. 52:3277-79
69. Lara M, Mutti FG, Glueck SM, Kroutil W. 2008. Biocatalytic cleavage of alkenes with O2 and Trametes hirsuta G FCC 047. Eur. J. Organ. Chem. 2008(21):3668-72
70. Rajagopalan A, Mutti FG, Kroutil W. 2012. Biocatalytic cleavage of alkenes with oxygen and Trametes hirsuta G FCC047. In PracticalMethods for Biocatalysis and Biotransformations 2, ed. J. Whittall, P. Sutton, pp. 199-202. West Sussex, UK:Wiley. 388 pp.
71. Lara M, Mutti FG, Glueck SM, Kroutil W. 2009. Oxidative enzymatic alkene cleavage: indications for a nonclassical enzyme mechanism. J. Am. Chem. Soc. 131:5368-69
72. Rajagopalan A, SchoberM,Emmerstorfer A, HammererL,Migglautsch A, et al. 2013. Enzymatic aerobic alkene cleavage catalyzed by a Mn3+-dependent proteinase A homologue. ChemBioChem 14:2427-30
73. Wallner S, Winkler A, Riedl S, Dully C, Horvath S, et al. 2012. Catalytic and structural role of a conserved active site histidine in berberine bridge enzyme. Biochemistry 51:6139-47
74. Schrittwieser JH, Resch V, Sattler JH, Lienhart WD, Durchschein K, et al. 2011. Biocatalytic enantioselective oxidative C-C coupling by aerobic C-H activation. Angew. Chem. Int. Ed. 50:1068-71
75. Resch V, Schrittwieser JH, Wallner S, Macheroux P, Kroutil W. 2011. Biocatalytic oxidative C-C bond formation catalysed by the berberine bridge enzyme: optimal reaction conditions. Adv. Synth. Catal. 353:2377-83
76. Schrittwieser JH, Groenendaal B, Resch V, Ghislieri D, Wallner S, et al. 2014. Deracemization by simultaneous bio-oxidative kinetic resolution and stereoinversion. Angew. Chem. Int. Ed. 53:3731-34
77. Ghislieri D, Green AP, Pontini M, Willies SC, Rowles I, et al. 2013. Engineering an enantioselective amine oxidase for the synthesis of pharmaceutical building blocks and alkaloid natural products. J. Am. Chem. Soc. 135:10863-69
78. Atkin KE, Reiss R, Koehler V, Bailey KR, Hart S, et al. 2008. The structure of monoamine oxidase from Aspergillus niger provides a molecular context for improvements in activity obtained by directed evolution. J. Mol. Biol. 384:1218-31
79. Eve TSC,Wells A, Turner NJ. 2007. Enantioselective oxidation of O-methyl-N-hydroxylamines using monoamine oxidase N as catalyst. Chem. Commun. 2007(15):1530-31
80. Kohler V, Bailey KR, Znabet A, Raftery J, Helliwell M, Turner NJ. 2010. Enantioselective biocatalytic oxidative desymmetrization of substituted pyrrolidines. Angew. Chem. Int. Ed. 49:2182-84
81. Znabet A, Polak MM, Janssen E, de Kanter FJJ, Turner NJ, et al. 2010. A highly efficient synthesis of telaprevir by strategic use of biocatalysis and multicomponent reactions. Chem. Commun. 46:7918-20
82. O'Reilly E, Iglesias C, Ghislieri D, Hopwood J, Galman JL, et al. 2014. A regio-and stereoselective w-transaminase/monoamine oxidase cascade for the synthesis of chiral 2,5-disubstituted pyrrolidines. Angew. Chem. Int. Ed. 53:2447-50
83. Constable DJC, Dunn PJ, Hayler JD, Humphrey GR, Leazer JL, et al. 2007. Key green chemistry research areas-a perspective from pharmaceutical manufacturers. Green Chem. 9:411-20
84. Brunhuber NMW, Thoden JB, Blanchard JS, Vanhooke JL. 2000. Rhodococcus L-phenylalanine dehydrogenase: kinetics, mechanism, and structural basis for catalytic specificity. Biochemistry 39:9174-87
85. Ringenberg MR, Ward TR. 2011. Merging the best of two worlds: artificial metalloenzymes for enantioselective catalysis. Chem. Commun. 47:8470-76
86. Lo C, Ringenberg MR, Gnandt D, Wilson Y, Ward TR. 2011. Artificial metalloenzymes for olefin metathesis based on the biotin-(strept)avidin technology. Chem. Commun. 47:12065-67
87. Durrenberger M, Ward TR. 2014. Recent achievements in the design and engineering of artificial metalloenzymes. Curr. Opin. Chem. Biol. 19:99-106
88. Mclntosh JA, Farwell CC, Arnold FH. 2014. Expanding P450 catalytic reaction space through evolution and engineering. Curr. Opin. Chem. Biol. 19:126-34
89. McIntosh JA, Coelho PS, Farwell CC, Wang ZJ, Lewis JC, et al. 2013. Enantioselective intramolecular C-H amination catalyzed by engineered cytochrome P450 enzymes in vitro and in vivo. Angew. Chem. Int. Ed. 52:9309-12
90. Wang ZJ, Peck NE, Renata H, Arnold FH. 2014. Cytochrome P450-catalyzed insertion of carbenoids into N-H bonds. Chem. Sci. 5:598-601
91. Dodani SC, Cahn JKB, Heinisch T, Brinkmann-Chen S, McIntosh JA, Arnold FH. 2014. Structural, functional, and spectroscopic characterization of the substrate scope of the novel nitrating cytochrome P450 TxtE. Chembiochem 15:2259-67
92. Coelho PS, Wang ZJ, Ener ME, Baril SA, Kannan A, et al. 2013. A serine-substituted P450 catalyzes highly efficient carbene transfer to olefins in vivo. Nat. Chem. Biol. 9:485-87
93. Wang ZJ, Renata H, Peck NE, Farwell CC, Coelho PS, Arnold FH. 2014. Improved cyclopropanation activity of histidine-ligated cytochrome P450 enables the enantioselective formal synthesis of levomilnacipran. Angew. Chem. Int. Ed. 53:6810-13
94. Khersonsky O, Rothlisberger D, Dym O, Albeck S, Jackson CJ, et al. 2010. Evolutionary optimization of computationally designed enzymes: Kemp eliminases of the KE07 series. J. Mol. Biol. 396:1025-42
95. Khersonsky O, Kiss G, Rothlisberger D, Dym O, Albeck S, et al. 2012. Bridging the gaps in design methodologies by evolutionary optimization of the stability and proficiency of designed Kemp eliminase KE59. Proc. Natl. Acad. Sci. USA 109:10358-63
96. Blomberg R, KriesH, PinkasDM, Mittl PRE, GrutterMG, et al. 2013. Precision is essential for efficient catalysis in an evolved Kemp eliminase. Nature 503:418-21
97. Hohne M, Bornscheuer UT. 2014. Protein engineering from scratch is maturing. Angew. Chem. Int. Ed. 53:1200-2
98. Patel JM. 2009. Biocatalytic synthesis of atorvastatin intermediates. J. Mol. Catal. B: Enzym. 61:123-28
99. Muller M. 2005. Chemoenzymatic synthesis of building blocks for statin side chains. Angew. Chem. Int. Ed. 44:362-65
100. Wolberg M, Hummel W, Wandrey C, Muller M. 2000. Highly regio-and enantioselective reduction of 3,5-dioxocarboxylates. Angew. Chem. Int. Ed. 39:4306-8
101. Wolberg M, Villela M, Bode S, Geilenkirchen P, Feldmann R, et al. 2008. Chemoenzymatic synthesis of the chiral side-chain of statins: application of an alcohol dehydrogenase catalysed ketone reduction on a large scale. Bioprocess Biosyst. Eng. 31:183-91
102. Wolberg M, Hummel W, Muller M. 2001. Biocatalytic reduction of diketo esters: a highly stereoselective approach to all four stereoisomers of a chlorinated dihydroxy hexanoate. Chem. Eur. J. 7:4562-71
103. Tao JH, Xu JH. 2009. Biocatalysis in development of green pharmaceutical processes. Curr. Opin. Chem. Biol. 13:43-50
104. Fox RJ, Davis SC, Mundorff EC, Newman LM, Gavrilovic V, et al. 2007. Improving catalytic function by ProSAR-driven enzyme evolution. Nat. Biotechnol. 25:338-44
105. Martinez CA, Hu S, Dumond Y, Tao J, Kelleher P, Tully L. 2008. Development of a chemoenzymatic manufacturing process for pregabalin. Organ. Process Res. Dev. 12:392-98
106. Winkler CK, Clay D, Davies S, O'Neill P, McDaid P, et al. 2013. Chemoenzymatic asymmetric synthesis of pregabalin precursors via asymmetric bioreduction of cyanoacrylate esters using ene-reductases. J. Organ. Chem. 78:1525-33
107. Winkler CK, Clay D, Turrini NG, Lechner H, Kroutil W, et al. 2014. Nitrile as activating group in the asymmetric bioreduction of cyanoacrylic acids catalyzed by ene-reductases. Adv. Synth. Catal. 356:1878-82
108. Hanson RL,Goldberg SL, BrzozowskiDB, Tully TP, CazzulinoD, et al. 2007. Preparation of an amino acid intermediate for the dipeptidyl peptidase IV inhibitor, saxagliptin, using a modified phenylalanine dehydrogenase. Adv. Synth. Catal. 349:1369-78
109. Savile CK, Janey JM, Mundorff EC,Moore JC, Tam S, et al. 2010. Biocatalytic asymmetric synthesis of chiral amines from ketones applied to sitagliptin manufacture. Science 329:305-9
110. Hall M, Bommarius AS. 2011. Enantioenriched compounds via enzyme-catalyzed redox reactions. Chem. Rev. 111:4088-110